Ravi Kumar Trivedi
Overview
Explore the profile of Ravi Kumar Trivedi including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
27
Citations
63
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
11.
Sulochana S, Trivedi R, Srinivas N, Mullangi R
Biomed Chromatogr
. 2020 Oct;
35(1):e4996.
PMID: 33047346
Immuno-oncology (IO) is an emerging option to treat cancer malignancies. In the last two years, IO has accounted for more than 90% of the new active drugs in various therapeutic...
12.
Gabani B, Saini N, Jairam R, Shrinivas P, Trivedi R, Srinivas N, et al.
Biomed Chromatogr
. 2020 Jul;
34(11):e4939.
PMID: 32614997
A selective, sensitive and rapid LC-MS/MS method has been developed and validated as per US Food and Drug Administration regulatory guidelines for the simultaneous quantitation of colchicine and febuxostat in...
13.
Zakkula A, Pulipati S, Dittakavi S, Bestha R, Zainuddin M, Trivedi R, et al.
Drug Res (Stuttg)
. 2020 Apr;
70(5):233-238.
PMID: 32289835
Filgotinib is a selective JAK1 (Janus kinase) inhibitor, filed in Japan for the treatment of rheumatoid arthritis. In this paper, we present the data of development and validation of a...
14.
Dixit A, Kiran V, Gabani B, Mohd Z, Trivedi R, Mullangi R
Biomed Chromatogr
. 2020 Jan;
34(4):e4802.
PMID: 31998982
Filgotinib is a selective JAK1 (Janus kinase) inhibitor, filed in Japan for the treatment of rheumatoid arthritis. In this paper, we report a validated liquid chromatography coupled with tandem mass...
15.
P S S, Trivedi R, Srinivas N, Mullangi R
Biomed Chromatogr
. 2019 Nov;
34(1):e4742.
PMID: 31749152
Quantitation of drugs used for the treatment of chronic lymphocytic leukemia in various biological matrices during both pre-clinical and clinical developments is very important, often in routine therapeutic drug monitoring....
16.
Kumar K, Rudra A, Sreedhara M, Siva Subramani T, Prasad D, Das M, et al.
Brain Behav Immun
. 2014 Jul;
42:204-11.
PMID: 25016199
Preclinical studies have shown that administration of Bacillus Calmette-Guérin (BCG) vaccine induces depression-like behaviors in mice; however, the effect of antidepressant drug treatment has not been reported earlier. In the...
17.
Woolf E, McDougall S, Fast D, Andraus M, Barfield M, Blackburn M, et al.
AAPS J
. 2014 Jun;
16(5):885-93.
PMID: 24961918
Consensus practices and regulatory guidance for liquid chromatography-mass spectrometry/mass spectrometry (LC-MS/MS) assays of small molecules are more aligned globally than for any of the other bioanalytical techniques addressed by the...
18.
Kelley M, Beaver C, Stevenson L, Bamford R, Gegwich P, Katsuhiko Y, et al.
AAPS J
. 2014 Jan;
16(2):221-5.
PMID: 24395373
The L1 Global Harmonization Team provides recommendations specifically for run acceptance of ligand binding methods used in bioanalysis of macromolecules in support of pharmacokinetics. The team focused on standard curve...
19.
Kurawattimath V, Pocha K, Mariappan T, Trivedi R, Mandlekar S
Eur J Drug Metab Pharmacokinet
. 2011 Sep;
37(1):23-30.
PMID: 21948266
Pharmacokinetic (PK) studies in mice usually require discrete and parallel blood sampling owing to a restriction on the volume of blood that can be withdrawn. This results in dosing large...
20.
Ramesh M, Trivedi R, Srinivas N
Bioanalysis
. 2010 Nov;
1(3):619-28.
PMID: 21083157
The emergence of bioanalysis as a key tool in the drug-discovery and -development process has enabled the development of sensitive, precise and specific bioanalytical methods in recent years. These methods...